By Cocer Peptides 
1 month ago
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.
The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.
Introduction
TB 500 (Thymosin Beta-4 Fragment 17–23) is a bioactive fragment closely associated with multiple key processes in human physiology, particularly in tissue repair and cell migration.
Figure 1 The chemical structure of TB 500 Fragment (17–23).
Basic Information about TB 500 Fragment (17–23)
TB 500 Fragment (17–23) is the N-terminal acetylated 17–23 fragment of human thymosin beta-4 (Thymosin Beta-4). N-terminal acetylation plays a crucial role in regulating protein-protein interactions and intracellular localization. The presence of acetyl groups can alter the molecular charge distribution and spatial conformation, thereby influencing its ability to bind with other biomolecules. In the human body, thymosin β4 is a widely distributed peptide, and TB 500 Fragment (17–23), as its specific fragment, can be produced through endogenous proteolytic processes.
Mechanism of Action of TB 500 Fragment (17–23)
(1) Cell Migration and Chemotaxis
Effects on Endothelial Cells: TB 500 Fragment (17–23) promotes endothelial cell migration, a process critical for angiogenesis. During wound healing or tissue repair, endothelial cells must migrate to damaged sites to form new vascular networks, to supply oxygen and nutrients to the tissue. TB 500 Fragment (17–23) can enhance endothelial cell migration by activating a series of intracellular signaling pathways, such as the PI3K-Akt signaling pathway, which regulates the reorganization of the cellular cytoskeleton. Activation of the PI3K-Akt signaling pathway promotes the polymerization and depolymerization of actin, enabling cells to extend pseudopodia and move forward.
Chemotactic effect on immune cells: This fragment also exhibits chemotactic effects on immune cells, attracting macrophages, neutrophils, and other immune cells to sites of inflammation or injury. Macrophages play a key role in tissue repair, as they can clear damaged tissue and pathogens while secreting various growth factors and cytokines to promote tissue repair and regeneration. The TB 500 Fragment (17–23) binds to specific receptors on the surface of immune cells, activating intracellular signaling pathways to guide immune cells toward the site of injury.
(2) Tissue Repair and Regeneration
Promoting fibroblast proliferation and collagen synthesis: Fibroblasts are the primary cell type in connective tissue and are responsible for synthesizing and secreting extracellular matrix components such as collagen during wound healing. TB 500 Fragment (17–23) can stimulate fibroblast proliferation, increasing cell numbers and thereby accelerating collagen synthesis. This fragment can upregulate the expression of genes related to collagen synthesis, such as COL1A1 and COL3A1, while promoting post-translational modification of collagen within fibroblasts, thereby improving collagen quality and stability. These effects contribute to the formation of a robust extracellular matrix, promoting wound healing and tissue repair.
Repair of muscle tissue: In muscle injury repair, TB 500 Fragment (17–23) also plays a significant role. It promotes the activation and proliferation of satellite cells, which are myogenic stem cells in skeletal muscle with the ability to self-renew and differentiate into muscle fibers. TB 500 Fragment (17–23) regulates the MyoD-Myogenin signaling pathway within satellite cells, promoting their differentiation into myotubes, which then fuse to form new muscle fibers, thereby achieving muscle tissue repair and regeneration. This fragment can also reduce inflammatory responses after muscle injury, mitigating further damage to muscle tissue caused by inflammation.
(3) Anti-inflammatory effects
Inhibition of inflammatory factor expression: TB 500 Fragment (17–23) can inhibit the expression of various inflammatory factors, including tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β). These inflammatory factors play a key role in inflammatory responses, and their excessive expression can lead to the amplification and persistence of inflammation, causing tissue damage. TB 500 Fragment (17–23) can reduce the transcription and translation of inflammatory factors by inhibiting the activation of the nuclear factor-κB (NF-κB) signaling pathway, thereby alleviating the inflammatory response. NF-κB is an important transcription factor at the core of inflammatory signal transduction, and its activation can upregulate the expression of multiple inflammation-related genes.
Regulating the inflammatory response of immune cells: In addition to inhibiting the expression of inflammatory factors, TB 500 Fragment (17–23) can also regulate the inflammatory response of immune cells. It can inhibit the polarization of macrophages toward the pro-inflammatory type (M1 type) and promote their polarization toward the anti-inflammatory type (M2 type). M1-type macrophages primarily secrete pro-inflammatory factors, participating in the initiation and amplification of inflammation; whereas M2-type macrophages secrete anti-inflammatory factors, promoting tissue repair and immune regulation. TB 500 Fragment (17–23) regulates the polarization state of macrophages, directing the inflammatory response toward a direction favorable for tissue repair.
Applications of TB 500 Fragment (17–23) in the Medical Field
(1) Wound Healing
Skin wounds: In skin wound healing, TB 500 Fragment (17–23) demonstrates significant promotional effects. Preclinical studies indicate that topical application of formulations containing TB 500 Fragment (17–23) accelerates wound closure and improves healing quality. This is primarily due to its multifaceted regulatory effects on endothelial cells, fibroblasts, and immune cells. Accelerated endothelial cell migration promotes new blood vessel formation, providing adequate nutrition to the wound; increased fibroblast proliferation and collagen synthesis result in more robust connective tissue at the wound site; and the chemotactic and anti-inflammatory effects of immune cells mitigate the inhibitory impact of inflammatory responses on wound healing. In the treatment of certain chronic wounds, such as diabetic foot ulcers, TB 500 Fragment (17–23) also demonstrates potential therapeutic value. Diabetic patients experience delayed wound healing and increased infection risk due to elevated blood sugar levels. TB 500 Fragment (17–23) can improve the local microenvironment, promote cell migration and proliferation, and enhance the likelihood of healing in chronic wounds.
Internal tissue wounds: For internal tissue wounds, such as gastrointestinal ulcers and liver damage, TB 500 Fragment (17–23) also has potential therapeutic effects. In a gastrointestinal ulcer model, administration of TB 500 Fragment (17–23) promotes the proliferation and repair of mucosal cells at the ulcer site, reducing ulcer area. Its mechanism of action is associated with promoting cell migration, regulating inflammatory responses, and increasing extracellular matrix synthesis. In a liver injury model, TB 500 Fragment (17–23) can promote liver cell regeneration, reduce inflammatory damage to liver tissue, and improve liver function indicators.
(2) Treatment of Musculoskeletal Diseases
Muscle strains and injuries: In sports medicine, muscle strains and injuries are common issues. TB 500 Fragment (17–23), due to its reparative effects on muscle tissue, has emerged as a potential therapeutic agent for muscle injuries. Administration of TB 500 Fragment (17–23) following a muscle strain can accelerate the recovery of muscle strength and reduce the occurrence of muscle fibrosis. Muscle fibrosis is a common complication following muscle injury, leading to hardening of muscle tissue, reduced elasticity, and impaired muscle function. TB 500 Fragment (17–23) promotes the activation and proliferation of satellite cells, inhibits inflammatory responses, and reduces the formation of muscle fibrosis, thereby enhancing the repair of muscle injuries.
Osteoarthritis: Osteoarthritis is a common degenerative joint disease characterized by cartilage damage, synovial inflammation, and bone proliferation. TB 500 Fragment (17–23) has also shown potential in the treatment of osteoarthritis. It can promote the proliferation and matrix synthesis of chondrocytes, inhibit chondrocyte apoptosis, thereby slowing down cartilage degeneration. The anti-inflammatory effects of TB 500 Fragment (17–23) can alleviate synovial inflammation, relieve joint pain, and reduce swelling. Animal studies have shown that intra-articular injection of TB 500 Fragment (17–23) can improve joint function in osteoarthritis model animals and reduce cartilage damage.
(3) Treatment of cardiovascular diseases
Myocardial infarction: Myocardial infarction is a severe cardiovascular disease caused by myocardial ischemia and necrosis due to coronary artery obstruction. TB 500 Fragment (17–23) has potential application value in the treatment of myocardial infarction. Following myocardial infarction, myocardial tissue undergoes inflammatory responses and cell apoptosis, leading to impaired cardiac function. TB 500 Fragment (17–23) can improve cardiac function post-myocardial infarction by inhibiting inflammatory responses, reducing myocardial cell apoptosis, and promoting angiogenesis. Studies have shown that in animal models of myocardial infarction, the use of TB 500 Fragment (17–23) can reduce the infarct size, improve cardiac ejection fraction, and enhance cardiac contraction and relaxation functions.
Vascular injury repair: In cases of vascular injury, such as endothelial damage following vascular intervention, TB 500 Fragment (17–23) can promote endothelial cell migration and proliferation, accelerate endothelial repair, and reduce the risk of thrombus formation. Following vascular endothelial injury, exposed collagen beneath the endothelium can trigger platelet adhesion and aggregation, leading to thrombus formation. TB 500 Fragment (17–23) promotes endothelial cell repair, restoring vascular endothelial integrity, thereby reducing thrombus formation and protecting normal vascular function.
Conclusion
TB 500 Fragment (17–23), as a peptide fragment with unique biological activity, demonstrates efficacy in tissue repair, cell migration, and other areas.
Sources
[1] Esposito S, Deventer K, Goeman J, et al. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential[J]. Drug Testing and Analysis, 2012,4(9):733-738.DOI:10.1002/dta.1402.
Product available for research use only:
